Implications of thiazolidinedione use and cardiovascular risk: is it all about the sugar?
Krantz
Mori J
MJ
Colorado Prevention Center and the Cardiology Division, Department of Medicine, School of Medicine, University of Colorado, Denver, Colorado 80203, USA. mori.krantz@cpcmed.org
D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D048909:Diabetes Complications / Q000453:epidemiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D018570:Risk Assessment; D045162:Thiazolidinediones / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones